Recalls from BioFire Diagnostics, LLC

• BioFire FilmArray Pneumonia and Joint Infection Panels (opens in a new tab)
  Moderate risk, FDA, Oct 13, 2026, Device defect
• BIOFIRE Respiratory Panel 2.1 (RP2.1) (opens in a new tab)
  Moderate risk, FDA, Aug 12, 2026, Device defect
• BioFire Joint Infection (JI) Panel (opens in a new tab)
  Moderate risk, FDA, May 6, 2026, Contamination
• Biofire Spotfire Respiratory/Sore Throat Panel (opens in a new tab)
  Moderate risk, FDA, May 6, 2026, Device defect

Data: Recall Canary (opens in a new tab)